EISSN 2148-5607

TJG is categorized as Q3 in JIF. TJG IS INDEXED IN SCI-EXPANDED AND PUBMED IMPACT FACTOR: 1.6

Turkish Journal of Gastroenterology

36 433 2025

HIGHLY CITED ARTICLES

Correlation Between Kidney Function and Intestinal Biological Characteristics of Adenine and Folium SennaeInduced Diarrhea Model in Mice

Xiaoya Li, Jiayuan Zhu, Yi Wu, Zhoujin Tan

Management of Primary Biliary Cholangitis: Current Treatment and Future Perspectives

Bernel et al.

Coffee-Derived Exosome-Like Nanoparticles: Are They the Secret Heroes?

Kantarcıoğlu et al.

Epigenetics of Inflammatory Bowel Diseases

Törüner and Ünal

Vonoprazan on the Eradication of Helicobacter pylori Infection

Huang and Lin

Acute Pancreatitis Review

Huang and Badurdeen

ERCP for acute cholangitis

Khamaysi and Taha

Inborn metabolic causes of fatty liver disease

Yıldız and Sivri

Gastric and small intestinal TSA

Kiremitci et al.

COVID-19 in Hepatology and Liver transplantation

Kabaçam et al.

Submission to First Decision = 31 Days

Editorial

The efficacy of pegylated interferon alpha 2a or 2b plus ribavirin in chronic hepatitis C patients

Necati YENİCE ¹ , Özgür MEHTAP ² , Mübeccel GÜMRAH ² , Nurten ARICAN ²

Author Affiliation(s)

1.

Department of Gastroenterology, Okmeydanı Research and Training Hospital, İstanbul

2.

Department of Internal Medicine 3rd Section, Okmeydanı Training Hospital, İstanbul, Turkey

Turk J Gastroenterol 2006; 17: 94-98

Keywords : Pegylated interferon alpha 2a, pegylated interferon alpha 2b, ribavirin, chronic hepatitis C

Read: 1839 Downloads: 2237 Published: 25 July 2019

Volume 17, Issue 2, June 2006

Previous Article

Files